NEW YORK (360Dx) – A test from Quidel to detect antibodies to the bacterial pathogen that causes Lyme disease has been cleared and CLIA waived by the US Food and Drug Administration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.